SOPHiA Genetics (SOPH)

Company Profile

SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. Where others see data, we see answers.

Company profile

Ticker

SOPH

Exchange

Incorporated

Location

Fiscal year end

Sector

Manufacturing > Biological Product (except Diagnostic) Manufacturing

Industry (SIC)

Biological Products, (No Diagnostic Substances)

AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Bio-Techne • Sana Biotechnology • Ginkgo Bioworks • Exelixis ...

SEC CIK

0001840706

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

SOPH stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$7.50

Low target

$5.00

High target

$10.00

Latest filings (excl ownership)

View all

6-K

Invitation to the Annual General Meeting

17 May 23

6-K

Current report (foreign)

12 May 23

6-K

Index to Consolidated Financial Statements

9 May 23

6-K

SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis

14 Mar 23

20-F

2022 FY

Annual report (foreign)

7 Mar 23

6-K

SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

7 Mar 23

6-K

SOPHiA GENETICS Expands Partnership with AstraZeneca to include Multimodal Approaches for Cancer Drug Development

13 Feb 23

6-K

Current report (foreign)

10 Jan 23

6-K

Index to Consolidated Financial Statements

8 Nov 22

6-K

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

1 Nov 22

Transcripts

SOPH

Earnings call transcript

2022 Q4

7 Mar 23

SOPH

Earnings call transcript

2022 Q3

12 Nov 22

SOPH

Earnings call transcript

2022 Q2

13 Aug 22

SOPH

Earnings call transcript

2021 Q4

15 Mar 22

Latest ownership filings

GENERATION INVESTMENT MANAGEMENT LLP

GENERATION INVESTMENT MANAGEMENT LLP

Balderton Capital VI, S.L.P.

10 Feb 22

SC 13G

GENERATION INVESTMENT MANAGEMENT LLP

6 Jan 22

Financial summary

Financial statements Chart SOPH financial data

Quarter (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q4 2022

SOPH institutional ownership history Ownership history

46.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	33	35	-5.7%
Opened positions	1	5	-80.0%
Closed positions	3	5	-40.0%
Increased positions	10	11	-9.1%
Reduced positions	11	7	+57.1%

13F shares	Current	Prev Q	Change
Total value	35.17 bn	9.59 bn	+266.6%
Total shares	29.74 mm	31.10 mm	-4.4%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Marc Coucke	6.99 mm	$98.61 mm	0.0%
Generation Investment Management	6.79 mm	$13.99 bn	0.0%
Balderton Capital VI, S.L.P.	3.36 mm	$47.40 mm	0.0%
Banque Pictet & Cie	2.19 mm	$4.51 bn	+0.7%
Credit Suisse	1.95 mm	$4.03 bn	+5.7%
Alta Wealth Advisors	1.41 mm	$2.90 bn	0.0%
PFG Principal Financial Group Inc - Registered Shares	1.40 mm	$2.88 bn	-4.6%
Jennison Associates	1.21 mm	$2.49 bn	-2.8%
GE General Electric	1.11 mm	$2.29 mm	0.0%
T. Rowe Price	915.27 k	$1.89 mm	-4.2%

Largest transactions	Shares	Bought/sold	Change
Partner Fund Management	0.00	-879.91 k	EXIT
MS Morgan Stanley	19.93 k	-424.09 k	-95.5%
Pura Vida Investments	754.04 k	-142.20 k	-15.9%
Credit Suisse	1.95 mm	+105.10 k	+5.7%
FHI Federated Hermes	100.00 k	+100.00 k	NEW
PFG Principal Financial Group Inc - Registered Shares	1.40 mm	-67.59 k	-4.6%
T. Rowe Price	915.27 k	-40.24 k	-4.2%
Jennison Associates	1.21 mm	-34.19 k	-2.8%
JPM JPMorgan Chase & Co.	31.39 k	+30.41 k	+3090.2%
UBS UBS Group AG - Registered Shares	17.98 k	-27.74 k	-60.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.